Special-interest research group session (ICDM) | Wednesday, 06 November 15:00~16:30 / Convention hall A Chair: Jin Han |
OT1 Upcoming new class of diabetic medication; SGLT2 inhibitor (AASD) |
Friday, 8 November 15:00~16:30 / Convention hall B Chair: Jin-Woo Kim |
OT2 Endocrine disrupting chemicals and diabetes mellitus (ICDM) | Friday, 8 November 15:00~16:30 / Grand ballroom A Chair: Yun-Chul Hong |
OT3 Lessons from clinical trials with incretin-based therapies (AASD) | Saturday, 9 November 14:30~16:00 / Emerald hall B Chair: Moon-Gi Choi |